Adverse Outcome Pathway on antagonist binding to PPARα leading to body-weight loss:

The present AOP describes antagonistic chemical binding to the peroxisome proliferator-activated receptor α (PPARα), resulting in preferential binding a co-repressor to the overall PPARα signalling complex causing a chain of events that includes: antagonism of PPARα nuclear signalling, decreased tra...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Gust, Kurt A.. (VerfasserIn)
Weitere Verfasser: Wilbanks, Mitchell S.. (MitwirkendeR), Collier, Zachary A.. (MitwirkendeR), Burgoon, Lyle D.. (MitwirkendeR), Perkins, Edward J.. (MitwirkendeR)
Format: Elektronisch E-Book
Sprache:English
Veröffentlicht: Paris OECD Publishing 2019
Schriftenreihe:OECD Series on Adverse Outcome Pathways no.10
Schlagworte:
Online-Zugang:Volltext
Zusammenfassung:The present AOP describes antagonistic chemical binding to the peroxisome proliferator-activated receptor α (PPARα), resulting in preferential binding a co-repressor to the overall PPARα signalling complex causing a chain of events that includes: antagonism of PPARα nuclear signalling, decreased transcriptional expression of PPARα-regulated genes that support energy metabolism, inhibited metabolic energy production (decreased fatty acid beta oxidation and ketogenesis), and increase in catabolism of muscle protein, culminating with starvation-like weight loss. The AOP is likely to be synergised during fasting, starvation or malnutrition events. The adverse outcome of this AOP is body-weight loss, which within the context of dynamic energy budget theory, decreases energy allocations to organismal maturation and reproduction and has been demonstrated to negatively affect ecological fitness.
Beschreibung:1 Online-Ressource (83 p.)
DOI:10.1787/29d4e08d-en

Es ist kein Print-Exemplar vorhanden.

Volltext öffnen